{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Liver+Injury", "query": { "condition": "Liver Injury" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 120, "total_pages": 12, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Liver+Injury&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-06-10T16:57:26.748Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT03468140", "title": "Pilot Trial of Eculizumab Therapy to Reduce Preservation Injury in Human Macrosteatotic Liver Transplantation", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "EARLY_PHASE1" ], "conditions": [ "End Stage Liver Disease" ], "interventions": [ { "name": "Eculizumab", "type": "DRUG" }, { "name": "No intervention", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Yale University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 0, "start_date": "2021-10-01", "completion_date": "2023-12-31", "has_results": false, "last_update_posted_date": "2021-04-08", "last_synced_at": "2026-06-10T16:57:26.748Z", "location_count": 1, "location_summary": "New Orleans, Louisiana", "locations": [ { "city": "New Orleans", "state": "Louisiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT03468140" }, { "nct_id": "NCT04563026", "title": "A Phase 2b Study in Subjects With Alcoholic Hepatitis to Evaluate Safety and Efficacy of DUR-928 Treatment", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Alcoholic Hepatitis" ], "interventions": [ { "name": "DUR-928 30 mg", "type": "DRUG" }, { "name": "DUR-928 90 mg", "type": "DRUG" }, { "name": "Placebo+ Standard of Care (SOC)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Durect", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 307, "start_date": "2021-01-22", "completion_date": "2023-09-06", "has_results": false, "last_update_posted_date": "2024-09-05", "last_synced_at": "2026-06-10T16:57:26.748Z", "location_count": 48, "location_summary": "Birmingham, Alabama • Phoenix, Arizona • Coronado, California + 33 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Coronado", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04563026" }, { "nct_id": "NCT01413620", "title": "Vitamin E Supplementation in Burn Patients", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Burn Injury" ], "interventions": [ { "name": "dl-alpha-tocopheryl acetate", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Shriners Hospitals for Children", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "6 Months", "maximum_age": "85 Years", "sex": "ALL", "summary": "6 Months to 85 Years" }, "enrollment_count": 0, "start_date": "2011-08", "completion_date": "2021-08", "has_results": false, "last_update_posted_date": "2021-09-21", "last_synced_at": "2026-06-10T16:57:26.748Z", "location_count": 1, "location_summary": "Galveston, Texas", "locations": [ { "city": "Galveston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01413620" }, { "nct_id": "NCT04258423", "title": "Everolimus Plus Mycophenolic Acid for Kidney Preservation in Liver Transplant Recipients With Impaired Kidney Function", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Kidney Failure" ], "interventions": [ { "name": "Tacrolimus", "type": "DRUG" }, { "name": "Everolimus", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Indiana University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 4, "start_date": "2019-12-19", "completion_date": "2020-06-27", "has_results": true, "last_update_posted_date": "2023-05-24", "last_synced_at": "2026-06-10T16:57:26.748Z", "location_count": 1, "location_summary": "Indianapolis, Indiana", "locations": [ { "city": "Indianapolis", "state": "Indiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT04258423" }, { "nct_id": "NCT00948194", "title": "Effect of Nitric Oxide (NO) on Ischemic/Reperfusion Injury During Extended Donor Criteria (EDC) Liver Transplantation", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Liver Transplantation", "Ischemia/Reperfusion Injury", "Oxidative Injury" ], "interventions": [ { "name": "Nitric Oxide", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Colorado, Denver", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "69 Years", "sex": "ALL", "summary": "18 Years to 69 Years" }, "enrollment_count": 13, "start_date": "2009-10", "completion_date": "2015-12", "has_results": true, "last_update_posted_date": "2021-05-28", "last_synced_at": "2026-06-10T16:57:26.748Z", "location_count": 1, "location_summary": "Aurora, Colorado", "locations": [ { "city": "Aurora", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT00948194" }, { "nct_id": "NCT04846010", "title": "Recovering Damaged Cells for Sequelae Caused by COVID-19, SARS-CoV-2", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Sequelae of; Infection", "Post Infection Glomerulonephritis", "Post-Infectious Peripheral Neuralgia", "Post-Infectious Disorder (Disorder)", "Post-Infectious Arthritis", "Post-Infectious Polyneuritis", "Post-Infectious Parkinsonism", "Post-Infectious Hypothyroidism", "Post Infectious Osteoarthritis", "Anxiety Disorders", "Depression", "Depression, Anxiety", "Depression, Bipolar", "Insomnia", "GERD", "Gastro Esophageal Reflux", "Hepatitis", "Glomerulonephritis" ], "interventions": [ { "name": "PurWet", "type": "COMBINATION_PRODUCT" }, { "name": "FurFat", "type": "COMBINATION_PRODUCT" }, { "name": "PurApo", "type": "COMBINATION_PRODUCT" }, { "name": "PurPhl", "type": "COMBINATION_PRODUCT" }, { "name": "PurClo", "type": "COMBINATION_PRODUCT" }, { "name": "PurInf", "type": "COMBINATION_PRODUCT" }, { "name": "Smoliv", "type": "COMBINATION_PRODUCT" } ], "intervention_types": [ "COMBINATION_PRODUCT" ], "sponsor": "All Natural Medicine Clinic, LLC", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 2000, "start_date": "2021-03-01", "completion_date": "2022-10-01", "has_results": false, "last_update_posted_date": "2021-05-26", "last_synced_at": "2026-06-10T16:57:26.748Z", "location_count": 1, "location_summary": "Rockville, Maryland", "locations": [ { "city": "Rockville", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT04846010" }, { "nct_id": "NCT05517668", "title": "Evaluation of the Efficacy of Fomepizole in the Treatment of Acetaminophen Overdose", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Acetaminophen", "Drug Overdose", "Acetaminophen Overdose", "Acetaminophen Poisoning", "Drug-induced Liver Injury", "Liver Failure", "Liver Toxicity" ], "interventions": [ { "name": "Intravenous infusion of N-acetylcysteine", "type": "DRUG" }, { "name": "Intravenous infusion of Fomepizole (4-MP)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Richard Dart, MD, PhD", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "10 Years", "maximum_age": "99 Years", "sex": "ALL", "summary": "10 Years to 99 Years" }, "enrollment_count": 29, "start_date": "2022-09-12", "completion_date": "2025-11-08", "has_results": false, "last_update_posted_date": "2025-11-25", "last_synced_at": "2026-06-10T16:57:26.748Z", "location_count": 1, "location_summary": "Denver, Colorado", "locations": [ { "city": "Denver", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT05517668" }, { "nct_id": "NCT06285253", "title": "miroliverELAP® for the Treatment of Acute Liver Failure: A Phase 1 Trial", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Acute Liver Failure", "Acute Liver Injury, Drug Induced", "Acute on Chronic Liver Failure (ACLF)", "Acute Alcoholic Hepatitis" ], "interventions": [ { "name": "miroliverELAP treatment", "type": "COMBINATION_PRODUCT" } ], "intervention_types": [ "COMBINATION_PRODUCT" ], "sponsor": "Miromatrix Medical Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 10, "start_date": "2024-10-05", "completion_date": "2026-01-22", "has_results": false, "last_update_posted_date": "2026-03-06", "last_synced_at": "2026-06-10T16:57:26.748Z", "location_count": 8, "location_summary": "Chicago, Illinois • Ann Arbor, Michigan • Minneapolis, Minnesota + 5 more", "locations": [ { "city": "Chicago", "state": "Illinois" }, { "city": "Ann Arbor", "state": "Michigan" }, { "city": "Minneapolis", "state": "Minnesota" }, { "city": "Rochester", "state": "Minnesota" }, { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT06285253" }, { "nct_id": "NCT06000748", "title": "NEPH-ROSIS (NEPHrology in CirRhOSIS) Pilot Trial: A Trial to Treat Acute Kidney Injury Among Hospitalized Cirrhosis Patients", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Acute Kidney Injury", "Cirrhosis", "Portal Hypertension", "Hepatorenal Syndrome", "Acute Tubule Necrosis", "Prerenal Failure" ], "interventions": [ { "name": "MAP-Target Algorithm", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of California, San Francisco", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 6, "start_date": "2024-02-01", "completion_date": "2024-07-31", "has_results": false, "last_update_posted_date": "2025-05-15", "last_synced_at": "2026-06-10T16:57:26.748Z", "location_count": 1, "location_summary": "San Francisco, California", "locations": [ { "city": "San Francisco", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06000748" }, { "nct_id": "NCT01137591", "title": "Acetaminophen in Combination With N-Acetylcysteine (NAC) Versus Placebo in Treating Fever", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Liver Failure", "Liver Failure, Acute", "Drug Induced Liver Injury", "Prevention & Control", "Fever" ], "interventions": [ { "name": "APAP and NAC combination", "type": "DRUG" }, { "name": "APAP and Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Columbia University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 0, "start_date": "2009-04", "completion_date": null, "has_results": false, "last_update_posted_date": "2015-03-05", "last_synced_at": "2026-06-10T16:57:26.748Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT01137591" } ] }